Zosano Pharma Corp·4

Feb 28, 4:15 PM ET

Kitchener Gregory David 4

4 · Zosano Pharma Corp · Filed Feb 28, 2019

Insider Transaction Report

Form 4
Period: 2019-02-26
Kitchener Gregory David
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-02-26+25,00025,000 total
    Exercise: $4.78Exp: 2029-02-26Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying the stock option will vest on February 26, 2020, and the remaining shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary thereafter, so that all shares shall have vested on February 26, 2023.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4